$RYTM Income Statement | Understand Stock

$RYTM

$89.47 +$0.20 (0.22%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product revenue, net
License revenue
Total revenues
Costs and expenses:
Cost of sales
Research and development
Selling, general, and administrative
License revenue
Total selling, general, and administrative

Total costs and expenses
Loss from operations
Other income (expense):
Other income
Interest income, net
Other income, net
Gain on settlement of forward contract
Interest expense
Interest income
Total other income (expense), net

Loss before income taxes
Provision for income taxes
Net loss
Accrued dividends on convertible preferred stock
Net loss attributable to common stockholders
Foreign currency translation adjustment
Unrealized (loss) gain, net on marketable securities, net of tax
Comprehensive loss
Net loss per share attributable to common stockholders, basic (in dollars per share)
Net loss per share attributable to common stockholders, diluted (in dollars per share)
Weighted-average common shares outstanding, basic (in shares)
Weighted-average common shares outstanding, diluted (in shares)

Comments